Figure 20

![Figure 20: Clinical and preclinical outcomes of creatine supplementation in aging populations are summarized (part 20), spanning cognitive function, bone density, and sarcopenia endpoints.]()

> Source: Rachel N Smith et al. "A review of creatine supplementation in age-related diseases: more than a supple." *F1000Research*, 2014. PMID: [25664170](https://pubmed.ncbi.nlm.nih.gov/25664170/)

<figure>
  <img src="" alt="Clinical and preclinical outcomes of creatine supplementation in aging populations are summarized (part 20), spanning cognitive function, bone density, and sarcopenia endpoints." />
  <figcaption>Figure 20. Clinical and preclinical outcomes of creatine supplementation in aging populations are summarized (part 20), spanning cognitive function, bone density, and sarcopenia endpoints.<br>  Source: Rachel N Smith et al. "A review of creatine supplementation in age-related diseases: more than a supple." <em>F1000Research</em>, 2014. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/25664170/">25664170</a></figcaption>
</figure>